强力霉素

强力霉素 基本信息
CAS号 564-25-0 分子式 C22H24N2O8
分子量 444.43500 精确质量 　444.15300
PSA 　181.62000 LogP 　0.35270
我要卖该产品 我要采购该产品

等价的CAS号：

564-25-0,3219-99-6,6543-77-7,22775-54-8,60080-38-8,97583-08-9
充值推广 查看更多供应商
目录
基本信息 制备方法与用途 物化性质 安全信息 合成路线 毒性 上下游

基本信息 展开↓

CAS号：
564-25-0
3D弹球模型：
立即前往扯扯看
分子式：
C22H24N2O8
分子量：
444.43500
中文名称：
强力霉素
英文名称：
doxycycline
中文别名：
强力霉素;
脱氧土霉素;
6-甲基-4-(二甲氨基)-3,5,10,12,12a-五羟基-1,11-二氧代-1,4,4a,5,5a,6,11,12a-八氢-2-并四苯甲酰胺
英文别名：
doxycycline;
Doxycen;
gs-3065;
spanor;
doxitard;
Doxycycline;
Monodox;
Unidox;
Ronaxan;
doxocycline;
doryx;
azudoxat;
Doxinyl
精确分子量/精确质量：
444.15300
极性分子表面积/PSA：
181.62000
油水分配系数/LogP：

LogP值指的是某物质在正辛醇/水两相体系中的分配系数的对数值，反映了物质在油水两相中的分配情况。其中、LogP值越大，说明该物质越亲油；反之，LogP值越小，则说明该物质越亲水。
EINECS：
209-271-1
InChI：
InChI=1/C22H24N2O8/c1-7-8-5-4-6-9(25)11(8)16(26)12-10(7)17(27)14-15(24(2)3)18(28)13(21(23)31)20(30)22(14,32)19(12)29/h4-7,10,14-15,17,25,27-29,32H,1-3H3,(H2,23,31)/t7-,10+,14+,15-,17-,22-/m0/s1

生产制备方法及用途展开↓

制备方法

用于敏感的革兰阳性菌和革兰阴性杆菌所致的上呼吸道感染、扁桃体炎、胆道感染、淋巴结炎、蜂窝组炎、老年慢性支气管炎等，也用于治疗斑疹伤寒、羌虫病、支原体肺炎等。尚可用于治疗霍乱，也可用于预防恶性疟疾和钩端螺旋体感染。主要用于敏感的革兰阳性球菌和革兰阴性杆菌所致的上呼吸道感染、扁桃体炎、胆道感染、淋巴结炎、蜂窝组织炎、老年慢性支气管炎等，也用于斑疹伤寒、恙虫病、支原体肺炎等。尚可用于治疗霍乱，也可用于预防恶性疟疾和勾端螺旋体感染。

用途简介

物化性质展开↓

外观与性状：
黄色晶体粉末
密度：
1.63 g/cm3
熔点：
206-209ºC
沸点：
685.2ºC at 760 mmHg
闪点：
414.99°C
折射率：
1.737

安全信息展开↓

海关代码：
3004909090

合成路线查看所有的合成路线

  • 3963-95-9

    盐酸甲烯土霉素

  • →

    ~98%

  • 564-25-0

    强力霉素

  • +

  • 3219-99-6

    6-环氧氯丙烷强力霉素

  • 10592-13-9

    盐酸强力霉素

  • →

  • 564-25-0

    强力霉素

毒理性展开↓

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QI8650000
CHEMICAL NAME :
2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,1 1,12a- octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-al pha-methyl-1,11-dioxo-
CAS REGISTRY NUMBER :
564-25-0
LAST UPDATED :
199609
DATA ITEMS CITED :
15
MOLECULAR FORMULA :
C22-H24-N2-O8
MOLECULAR WEIGHT :
444.48
WISWESSER LINE NOTATION :
L E6 C666 BV FV CU GUTTT&J DQ GVZ HQ IN1&1 KQ MQ M1 RQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
68 mg/kg/24D-I
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
378 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
228 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1870 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
410 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
241 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
750 mg/kg
SEX/DURATION :
female 2 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
3750 ug/L
REFERENCE :
BCPHBM British Journal of Clinical Pharmacology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.1- 1974- Volume(issue)/page/year: 16,127,1983 *** REVIEWS *** TOXICOLOGY REVIEW PBPSDY Pharmacological and Biochemical Properties of Drug Substances. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.1- 1977- Volume(issue)/page/year: 2,305,1979 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 84744 No. of Facilities: 641 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1281 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 84744 No. of Facilities: 450 (estimated) No. of Industries: 1 No. of Occupations: 5 No. of Employees: 22055 (estimated) No. of Female Employees: 18813 (estimated)

上下游相关产品

上游产品

更多

  • 3963-95-9

    盐酸甲烯土霉素

  • 10592-13-9

    盐酸强力霉素

下游产品

更多

  • 6543-77-7

    4-环氧氯丙烷强力霉素

  • 10592-13-9

    盐酸强力霉素

立即下载安装“化学加”APP
专业、功能强大，随时调用更加方便
下载APP